RIPPLE
Live / Applied — Priority action mailed (as of 07 Jan 2026)
What this means for you
Not registered yet, but its 20 Aug 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99348403
- Mark type
- Stylized text
- Filed
- 20 Aug 2025
- Attorney of record
- Dustin Luettgen
Goods and services
- Class 005 — Pharmaceuticals: Gene therapy preparations, namely, biological preparations for the treatment of human diseases or disorders, namely, diseases of genetic or genetic predisposition etiology; kits comprised of gene therapies, namely, biological preparations and pharmaceutical preparations both for the treatment of human diseases and disorders, namely, diseases of genetic or genetic predisposition etiology; gene delivery platform, namely, biological delivery agents for the treatment of human diseases and disorders, namely, diseases of genetic or genetic predisposition etiology
- Class 009 — Scientific and electric apparatus: Software for operation of ultrasound systems and ultrasound probes for administration of pharmaceutical agents, namely, biological preparations for the treatment of human diseases or disorders and gene therapy preparations
- Class 010 — Medical apparatus: Ultrasound systems and ultrasound probes for administration of pharmaceutical agents, namely, biological preparations for the treatment of human diseases or disorders and gene therapy preparations
- Class 042 — Scientific and technological services: Software as a service for the operation of ultrasound systems and ultrasound probes for administration of pharmaceutical agents, namely, biological preparations for the treatment of human diseases or disorders and gene therapy preparations; Research and development in the field of gene therapy
- Class 044 — Medical, beauty and agricultural services: Medical services for ultrasound mediated administration of pharmaceutical agents, namely, biological preparations for the treatment of human diseases or disorders and gene therapy preparations
Owner
- SonoThera, Inc., South San Francisco, CA, US
Prosecution history
- 23 Mar 2026 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 23 Mar 2026 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 23 Mar 2026 — PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
- 23 Mar 2026 — TEAS VOLUNTARY AMENDMENT RECEIVED
- 07 Jan 2026 — NOTIFICATION OF PRIORITY ACTION E-MAILED
- 07 Jan 2026 — PRIORITY ACTION E-MAILED
- 07 Jan 2026 — PRIORITY ACTION WRITTEN
- 06 Jan 2026 — ASSIGNED TO EXAMINER
- 20 Aug 2025 — APPLICATION FILING RECEIPT MAILED
- 20 Aug 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 20 Aug 2025 — NEW APPLICATION ENTERED